Summary
- Current Price
- As of today, KZIA price is $11.55, up +5.10% in the most recent trading session on
- Current Price All-Time High
- KZIA price is currently -99.89% below its historical high of $10,500.33 set on
- Market Cap
- KZIA current market cap is $132M, up +1652.53% over the past 365 days
- PE Ratio
- KZIA PE ratio is unknown
- Revenue
- KZIA current annual revenue is $27.20K, down -98.20% year-over-year
- Next Earnings
- The next earnings release for KZIA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Kazia Therapeutics Limited |
| Ticker | NASDAQ: KZIA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Australia |
| IPO | |
| Indexes | Not included |
| Website | kaziatherapeutics.com |
| Employees | 9 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $11.55 | ||
| Price, 1D Change | +5.10% | |
| $132M | ||
| - | ||
| - | ||
| 1.85 | ||
| $27K | ||
| Revenue, 1Y Change | -98.20% | |
| -$12.23 | ||
| EPS, 1Y Change | -83.82% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:5 | |
| Next Split | N/A | N/A |
| Last Ticker Change | NVGN | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$12.23 | ||
| EPS Estimate | -$0.02 | |
| EPS Est. Change | +99.87% | |
| $27.20K | ||
| Revenue Estimate | $357.00K | |
| Revenue Est. Change | +1,212.50% | |
| $11.55 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$6.66 | - | |
| -$3.33 | -$12.23 | -267.38% | |
| -$0.02 | N/A | +99.87% | |
| -$0.02 | N/A | +99.86% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $60.00K | $1.51M | +2,420.67% | |
| $59.00K | $27.20K | -53.90% | |
| $357.00K | N/A | +1,212.50% | |
| $117.00K | N/A | +330.15% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +104.42% | ||
| -82.50% | ||
| +1,652.53% | ||
| +389.28% | ||
| -98.20% | ||
| +100.00% | ||
| -83.82% | ||
| +82.13% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $11.55 | ||
| $8.67 | ||
| $11.35 | ||
| $9.50 | ||
| $11.44 | ||
| -$0.12 | ||
| 1.85 | ||
| $1.08 | ||
| 41.14 | ||
| 75.47% | ||
| 155.44% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $27.20K | ||
| -$12.23 | ||
| -$577.70K | ||
| -2,123.90% | ||
| -$10.36M | ||
| -38.11% | ||
| -$13.41M | ||
| -49.29% | ||
| -$9.76M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -0.05 | ||
| 0.35 | ||
| 0.35 | ||
| - | ||
| - | ||
| -33.14 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| -55.74 | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$5.44M | ||
| $2.85M | ||
| $3.97M | ||
| $3.23M | ||
| $9.41M | ||
| $9.21M | ||
| $259.50K | ||
| $259.50K | ||
| $3.70M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $13.43M | ||
| $9.79M | ||
| $604.90K | ||
| $0.00 | ||
| $604.90K | ||
| $0.00 | ||
| -$1.27M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$8.45M | ||
| $0.00 | ||
| $10.20M | ||
| $0.00 | ||
| -$8.45M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Laidlaw & Co. | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Maxim Group | → | |
| HC Wainwright & Co. | → | |
| Maxim Group | → | |
| Maxim Group | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Maxim Group | → |
Analyst sentiment
Institutional ownership
Screeners with KZIA
FAQ
What is the ticker symbol for Kazia Therapeutics Limited?
The ticker symbol for Kazia Therapeutics Limited is NASDAQ:KZIA
Does Kazia Therapeutics Limited pay dividends?
No, Kazia Therapeutics Limited does not pay dividends
What sector is Kazia Therapeutics Limited in?
Kazia Therapeutics Limited is in the Healthcare sector
What industry is Kazia Therapeutics Limited in?
Kazia Therapeutics Limited is in the Biotechnology industry
What country is Kazia Therapeutics Limited based in?
Kazia Therapeutics Limited is headquartered in Australia
When did Kazia Therapeutics Limited go public?
Kazia Therapeutics Limited initial public offering (IPO) was on January 6, 1999
Is Kazia Therapeutics Limited in the S&P 500?
No, Kazia Therapeutics Limited is not included in the S&P 500 index
Is Kazia Therapeutics Limited in the NASDAQ 100?
No, Kazia Therapeutics Limited is not included in the NASDAQ 100 index
Is Kazia Therapeutics Limited in the Dow Jones?
No, Kazia Therapeutics Limited is not included in the Dow Jones index
When was Kazia Therapeutics Limited last earnings report?
Kazia Therapeutics Limited's most recent earnings report was on June 10, 2025
When does Kazia Therapeutics Limited report earnings?
The next expected earnings date for Kazia Therapeutics Limited is June 10, 2026
Data Sources & References
- KZIA Official Website www.kaziatherapeutics.com
- KZIA Profile on Yahoo Finance finance.yahoo.com/quote/KZIA
- KZIA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/kzia